Tirzepatide
An injectable combination therapy formulated to improve blood sugar regulation, reduce appetite, and decrease inflammation. Tirzepatide acts on two key receptors—GLP-1 and GIP—to enhance insulin sensitivity, promote steady glucose control, and support significant weight reduction. Glycine, an amino acid, complements this mechanism by promoting cellular repair, reducing inflammation, and supporting lean muscle preservation during weight loss.
ACTIVE INGREDIENTS
Tirzepatide
A dual GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptor agonist that works synergistically to enhance insulin secretion, regulate appetite, and improve overall metabolic function—leading to improved blood sugar control and weight reduction.
Glycine
A supportive amino acid that helps maintain muscle mass and promotes recovery during weight loss by aiding cellular repair and reducing inflammation.
HOW TO USE
Suggested Administration:
Administer subcutaneously once weekly, on the same day each week, with or without food. Injections may be given in the abdomen, thigh, or upper arm, rotating sites with each dose. Dosage should begin at a low starting dose and be titrated gradually as directed by a healthcare provider to minimize gastrointestinal side effects and ensure optimal tolerance and efficacy.
SCHEDULE
RX Only
BUD
90
DISCLAIMER
This compounded medication is only available when the commercially available product is unavailable or when a prescriber determines that there is a clinically significant difference for the patient.
